PMI U.S. CEO Stacey Kennedy discusses the company’s mission to help smokers switch to better alternatives and investing in American workers and innovation.
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
FDA’s science-based decision makes ZYN the first authorized nicotine pouch product and affirms that ZYN nicotine pouches are a better alternative for adults who smoke or use other traditional tobacco products.
FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product
The FDA authorized the marketing of IQOS, an electrically heated tobacco system, as a modified risk tobacco product (MRTP). In doing so, the agency found that an IQOS exposure modification order is appropriate to promote the public health.
Too Many U.S. Physicians Remain in the Dark About...
America's next urgent challenge in ending smoking is ensuring that physicians and other medical providers understand the science behind tobacco harm reduction.
A new survey has found that 47% of U.S. healthcare practitioners—rising to 59% among medical professionals who indicate that half or more of their patients smoke cigarettes—mistakenly believe nicotine is a carcinogen.
PMI U.S. Reveals Ft. Lauderdale as Next IQOS Launch City...
PMI U.S. announced the introduction of its IQOS heated tobacco system in the greater Fort Lauderdale area, giving residents 21+ who consume nicotine the opportunity to join a waiting list to be among the first to try this innovative product.
Authorized by the U.S. Food and Drug Administration as a modified risk tobacco product, IQOS complements PMI U.S. portfolio—alongside ZYN nicotine pouches—to provide adult nicotine consumers 21+ with more smoke-free choices.
U.S. Surgeon recently released a report entitled on the disproportionate impact cigarette smoking has on certain communities and the associated public health implications.
Globally, PMI has invested more than $12.5 billion to develop satisfying smoke-free products to help people move away from more harmful forms of tobacco.
FDA Reauthorizes Swedish Match’s General snus as a...
Philip Morris International affiliate, Swedish Match, earned first-ever FDA authorization for a modified risk marketing claim and now is the first to achieve an FDA renewal.
PRICE: Declaring Independence From Smoking Should be...
To help the over 28 million Americans who smoke but don’t quit, leaders in Washington should make declaring independence from smoking a policy priority.
Swedish Match USA, Inc. Presents to U.S. Food and Drug...
Experts from Swedish Match USA, Inc., an affiliate of Philip Morris International Inc. presented to the Tobacco Products Scientific Advisory Committee (TPSAC) on General Snus MRTP renewal.
